Magnetic Resonance Imaging Characterization of Hemorrhagic Transformation of Embolic Stroke in the Rat

Intracranial hemorrhage is a critical factor when considering efficacy and safety of thrombolytic intervention after thromboembolic stroke. This study tested whether magnetic resonance imaging could identify tissue for hemorrhagic transformation after the onset of embolic stroke. Rats subjected to embolic stroke with and without recombinant tissue-type plasmogen activator (rt-PA) treatment were followed-up with magnetic resonance imaging using the inverse of the apparent forward transfer rate for magnetization transfer (kinv), gadolinium-chelate contrast-enhanced magnetic resonance imaging, and diffusion-, perfusion-, and T2-weighted imaging. Rats with embolic stroke either were treated with rt-PA 1 (n = 16) or 4 hours (n = 13) after stroke onset or were not treated (n = 15). From these groups, at total of 17 rats had intracerebral hemorrhage. Tissue progressing to hemorrhage and adjacent to the site of hemorrhage was analyzed to identify magnetic resonance imaging markers that characterize hemorrhagic transformation. The parameter maps of kinv and contrast-enhanced magnetic resonance imaging showed greater sensitivity in the detection of tissue destined for hemorrhagic transformation compared with the apparent diffusion coefficient of water (ADCw) and CBF. In tissue not destined to undergo hemorrhagic transformation, kinv maps and contrast-enhanced magnetic resonance imaging exhibited small increases in kinv and contrast-enhanced magnetic resonance imaging signal intensity in the area encompassing the territory supplied by the middle cerebral artery. In contrast, large increases in kinv and in signal intensity in the contrast-enhanced magnetic resonance images were detected in the region where gross hemorrhage was confirmed histologically. The values of kinv, T2, and signal intensity in the contrast-enhanced magnetic resonance images were significantly higher in the region destined for hemorrhagic transformation (kinv, P ⩽ 0.033 3–24 hours after embolization; T2, P ⩽ 0.037 24–48 hours; contrast-enhanced magnetic resonance imaging, P < 0.05 4–7 hours) compared with the nonhemorrhagic transformation ischemic region or in the contralateral homologous regions after onset of ischemia. Of these methods, kinv shows the most sensitivity in the detection of hemorrhagic transformation soon after embolization. The authors' data suggest that kinv and contrast-enhanced magnetic resonance imaging are potentially important methodologies for detecting tissue destined for hemorrhagic transformation.

[1]  M. Chopp,et al.  Temporal evolution and spatial distribution of the diffusion constant of water in rat brain after transient middle cerebral artery occlusion , 1993, Journal of the Neurological Sciences.

[2]  R. Bryan,et al.  Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction. , 1994, AJNR. American journal of neuroradiology.

[3]  R A Knight,et al.  Magnetic Resonance Imaging Indexes of Therapeutic Efficacy of Recombinant Tissue Plasminogen Activator Treatment of Rat at 1 and 4 Hours after Embolic Stroke , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  K. Welch,et al.  Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. , 1998, Stroke.

[5]  C. Poser,et al.  PATHOGENESIS OF HEMORRHAGIC INFARCTION OF THE BRAIN. II. PROTECTIVE EFFECT OF LOW MOLECULAR WEIGHT DEXTRAN. , 1963, Archives of neurology.

[6]  M. Chopp,et al.  Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. , 1999, Stroke.

[7]  L R Schad,et al.  Fast and precise T1 imaging using a TOMROP sequence. , 1990, Magnetic resonance imaging.

[8]  M. Fujishima,et al.  Hemorrhagic transformation in cerebral embolism. , 1989, Stroke.

[9]  R. Adams,et al.  Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. , 1951, Journal of neuropathology and experimental neurology.

[10]  L. Hayman,et al.  Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. , 1981, AJR. American journal of roentgenology.

[11]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[12]  K. Overgaard Thrombolytic therapy in experimental embolic stroke. , 1994, Cerebrovascular and brain metabolism reviews.

[13]  J. Lodder,et al.  Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. , 1986, Stroke.

[14]  C. Hornig,et al.  Hemorrhagic cerebral infarction--a prospective study. , 1986, Stroke.

[15]  J. Broderick,et al.  Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. , 1996, AJNR. American journal of neuroradiology.

[16]  J. Ogata,et al.  Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. , 1990, Stroke.

[17]  R. Swank,et al.  HEMORRHAGIC CEREBRAL INFARCTION BY ARTERIAL OCCLUSION: AN EXPERIMENTAL STUDY , 1952, Journal of neuropathology and experimental neurology.

[18]  Donald J. DeGracia,et al.  Brain μ‐Calpain Autolysis During Global Cerebral Ischemia , 1996 .

[19]  A. Faris,et al.  PATHOGENESIS OF HEMORRHAGIC INFARCTION OF THE BRAIN. I. EXPERIMENTAL INVESTIGATIONS OF ROLE OF HYPERTENSION AND OF COLLATERAL CIRCULATION. , 1963, Archives of neurology.

[20]  M. Chopp,et al.  Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat , 1994, Neurology.

[21]  Michael Chopp,et al.  A rat model of focal embolic cerebral ischemia , 1997, Brain Research.

[22]  G. Hamann,et al.  Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  L. Weisberg Nonseptic cardiogenic cerebral embolic stroke , 1985, Neurology.

[24]  W. Hacke,et al.  Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. , 1990, Stroke.

[25]  Jochen B. Fiebach,et al.  Intracranial hemorrhage , 2004, Neurocritical care.

[26]  M Chopp,et al.  Diffusion-, T2-, and Perfusion-Weighted Nuclear Magnetic Resonance Imaging of Middle Cerebral Artery Embolic Stroke and Recombinant Tissue Plasminogen Activator Intervention in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  J. Lodder,et al.  Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. , 1983, Stroke.

[28]  J. Broderick,et al.  Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke , 1994, Stroke.

[29]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[30]  A. D. de Crespigny,et al.  Improved Perfusion with rt-PA and Hirulog in a Rabbit Model of Embolic Stroke , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  S. Sakaki,et al.  Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. , 1994, Stroke.

[32]  R. Laureno,et al.  The diagnosis and management of cerebral embolism and haemorrhagic infarction with sequential computerized cranial tomography. , 1987, Brain : a journal of neurology.

[33]  J. A. Epstein,et al.  MASSIVE CEREBRAL HEMORRHAGE: SPONTANEOUS AND EXPERIMENTALLY INDUCED , 1953, Journal of neuropathology and experimental neurology.

[34]  V. Haughton,et al.  Effect of dose and field strength on enhancement with paramagnetic contrast media. , 1994, AJNR. American journal of neuroradiology.

[35]  A. Nath,et al.  Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. , 1984, Stroke.

[36]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  M Chopp,et al.  T1 and magnetization transfer at 7 Tesla in acute ischemic infarct in the rat , 1999, Magnetic resonance in medicine.

[38]  A. Haase,et al.  Rapid NMR imaging of dynamic processes using the FLASII technique , 1986, Magnetic resonance in medicine.

[39]  Lyden Pd,et al.  Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. , 1993, Cerebrovascular and brain metabolism reviews.

[40]  J. Lodder CT‐detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift , 1984, Acta neurologica Scandinavica.

[41]  D. S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.